Genomic response to vitamin D supplementation in the setting of a randomized, placebo-controlled trial
<h4>Background</h4> <p>Vitamin D deficiency has been associated with multiple diseases, but the causal relevance and underlying processes are not fully understood. Elucidating the mechanisms of action of drug treatments in humans is challenging, but application of functional genom...
Main Authors: | Berlanga-Taylor, A, Plant, K, Dahl, A, Lau, E, Hill, M, Sims, D, Heger, A, Emberson, J, Armitage, J, Clarke, R, Knight, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2018
|
Similar Items
-
Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial
by: Antonio J. Berlanga-Taylor, et al.
Published: (2018-05-01) -
Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
by: Clarke, R, et al.
Published: (2000) -
An integrated approach to defining genetic and environmental determinants for major clinical outcomes involving vitamin D
by: Berlanga-Taylor, A, et al.
Published: (2014) -
An integrated approach to defining genetic and environmental determinants for major clinical outcomes involving vitamin D.
by: Berlanga-Taylor, A, et al.
Published: (2014) -
Effects of Folic Acid Plus Vitamin B-12 vs Placebo in Myocardial Infarction Survivors Reply
by: Armitage, J, et al.
Published: (2010)